Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies

2022106 citationsJournal Articlegold Open Access

Authors

The KALM-1 trial is registered as NCT03422653 and the KALM-2 trial is registered as NCT03636269.

Good health and well-being

Published in: Kidney Medicine

Volume 4, Issue 8, pp. 100512-100512

Field-Weighted Citation Impact: 21.62